Your browser doesn't support javascript.
loading
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Zirwas, Matthew J; Draelos, Zoe D; DuBois, Janet; Kircik, Leon H; Moore, Angela Y; Stein Gold, Linda; Alonso-Llamazares, Javier; Bukhalo, Michael; Bruce, Suzanne; Eads, Kimmie; Green, Lawrence J; Guenthner, Scott T; Ferris, Laura K; Forman, Seth B; Kempers, Steven E; Lain, Edward; Lynde, Charles W; Pariser, David M; Toth, Darryl P; Yamauchi, Paul S; Higham, Robert C; Krupa, David; Burnett, Patrick; Berk, David R.
Afiliación
  • Zirwas MJ; Dermatologists of the Central States, Bexley, Ohio.
  • Draelos ZD; Probity Medical Research, Bexley, Ohio.
  • DuBois J; Ohio University, Bexley.
  • Kircik LH; Dermatology Consulting Services, High Point, North Carolina.
  • Moore AY; DermResearch, Inc, Austin, Texas.
  • Stein Gold L; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Alonso-Llamazares J; Physicians Skin Care, PLLC, Louisville, Kentucky.
  • Bukhalo M; Indiana Medical Center, Indianapolis.
  • Bruce S; Skin Sciences, PLLC, Louisville, Kentucky.
  • Eads K; Arlington Center for Dermatology, Arlington Research Center, Arlington, Texas.
  • Green LJ; Baylor University Medical Center, Dallas, Texas.
  • Guenthner ST; Henry Ford Medical Center, Detroit, Michigan.
  • Ferris LK; Driven Research LLC, Coral Gables, Florida.
  • Forman SB; Arlington Dermatology, Rolling Meadows, Illinois.
  • Kempers SE; SBA Dermatology, Houston, Texas.
  • Lain E; The Indiana Clinical Trials Center, PC, Plainfield.
  • Lynde CW; George Washington University School of Medicine, Rockville, Maryland.
  • Pariser DM; The Dermatology Center of Indiana, PC, Plainfield.
  • Toth DP; The Indiana Clinical Trials Center, PC, Plainfield.
  • Yamauchi PS; University of Pittsburgh, Department of Dermatology, Pittsburgh, Pennsylvania.
  • Higham RC; ForCare Medical Center, Tampa, Florida.
  • Krupa D; Minnesota Clinical Study Center, Fridley.
  • Burnett P; Sanova Dermatology, Austin, Texas.
  • Berk DR; University of Toronto, Toronto, Ontario, Canada.
JAMA Dermatol ; 159(6): 613-620, 2023 06 01.
Article en En | MEDLINE | ID: mdl-37133856
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Dermatitis Seborreica Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Dermatol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Dermatitis Seborreica Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Dermatol Año: 2023 Tipo del documento: Article